Literature DB >> 9285779

High expression of naked plasmid DNA in muscles of young rodents.

I Danko1, P Williams, H Herweijer, G Zhang, J S Latendresse, I Bock, J A Wolff.   

Abstract

There is a time window at 2 weeks of age for achieving very high levels of foreign gene expression from the intramuscular injection of naked plasmid DNA in mice and rats. The highest expression, over 1 microg of luciferase protein/muscle, was obtained in Balb/C mice using constructs containing the CMV promoter, a chimeric intron and the luc+ luciferase gene. Approximately 50% of the myofibers were intensely blue following the intramuscular injection of a beta-galactosidase expression vector in 2 week old Balb/C mice. The effects of age, mouse strain and construct were multiplicative, resulting in >1000-fold greater luciferase and approximately 20-fold more beta-galactosidase-positive cells. These high levels of expression were unstable and were not observed in larger animals (dog, rhesus monkey). These results indicate that enormous levels of foreign gene expression can be obtained in muscle with naked DNA in vivo and will enable the temporary effects of gene function and expression in rodent muscle to be expeditiously studied.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285779     DOI: 10.1093/hmg/6.9.1435

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  17 in total

Review 1.  Nucleic acid vaccines: tasks and tactics.

Authors:  B S McKenzie; A J Corbett; J L Brady; C M Dyer; R A Strugnell; S J Kent; D R Kramer; J S Boyle; A M Lew
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Gene doping in sports.

Authors:  Mehmet Unal; Durisehvar Ozer Unal
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

3.  Tissue-specific characteristics of in vivo electric gene: transfer by tissue and intravenous injection of plasmid DNA.

Authors:  Oranuch Thanaketpaisarn; Makiya Nishikawa; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

Review 4.  Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era.

Authors:  Evanthia Diamanti-Kandarakis; Panagiotis A Konstantinopoulos; Joanna Papailiou; Stylianos A Kandarakis; Anastasios Andreopoulos; Gerasimos P Sykiotis
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 5.  DNA and RNA-based vaccines: principles, progress and prospects.

Authors:  W W Leitner; H Ying; N P Restifo
Journal:  Vaccine       Date:  1999-12-10       Impact factor: 3.641

6.  Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.

Authors:  Carmen Bertoni; Sohail Jarrahian; Thurman M Wheeler; Yining Li; Eric C Olivares; Michele P Calos; Thomas A Rando
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-30       Impact factor: 11.205

7.  Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNA.

Authors:  Christine I Wooddell; Julia O Hegge; Guofeng Zhang; Magdolna G Sebestyén; Mark Noble; Jacob B Griffin; Loretta V Pfannes; Hans Herweijer; James E Hagstrom; Serge Braun; Thierry Huss; Jon A Wolff
Journal:  Hum Gene Ther       Date:  2011-04-18       Impact factor: 5.695

Review 8.  DNA vaccines: ready for prime time?

Authors:  Michele A Kutzler; David B Weiner
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

Review 9.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

10.  Changes in the reproductive function and developmental phenotypes in mice following intramuscular injection of an activin betaA-expressing plasmid.

Authors:  Mi-Nyeu Kim; Moon Nyeo Park; Hoi Kyung Jung; Chunghee Cho; Kelly E Mayo; Byung-Nam Cho
Journal:  Reprod Biol Endocrinol       Date:  2008-12-16       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.